{
    "title": "Interventions targeting the gut microbiota and their possible effect on gastrointestinal and neurobehavioral symptoms in autism spectrum disorder.",
    "doc_id": "40376856",
    "writer": "Takyi E",
    "year": "2025",
    "summary": "The modulation of the gut microbiota using MTT in ASD has shown beneficial and long-term effects on GI symptoms and core symptoms of autism. ...This review examines the current clinical research evidence for the use of interventions that target the microbiome â€¦",
    "abstract": "Autism spectrum disorder (ASD) is a developmental disorder that is characterized by deficits in social communication and restricted, repetitive, and stereotyped behaviors. In addition to neurobehavioral symptoms, children with ASD often have gastrointestinal symptoms (e.g. constipation, diarrhea, gas, abdominal pain, reflux). Several studies have proposed the role of gut microbiota and metabolic disorders in gastrointestinal symptoms and neurodevelopmental dysfunction in ASD patients; these results offer promising avenues for novel treatments of this disorder. Interventions targeting the gut microbiota - such as fecal microbiota transplant (FMT), microbiota transplant therapy (MTT), probiotics, prebiotics, synbiotics, antibiotics, antifungals, and diet - promise to improve gut health and can potentially improve neurological symptoms. The modulation of the gut microbiota using MTT in ASD has shown beneficial and long-term effects on GI symptoms and core symptoms of autism. Also, the modulation of the gut microbiota to resemble that of typically developing individuals seems to be the most promising intervention. As most of the studies carried out with MTT are open-label studies, more extensive double-blinded randomized control trials are needed to confirm the efficacy of MTT as a therapeutic option for ASD. This review examines the current clinical research evidence for the use of interventions that target the microbiome - such as antibiotics, antifungals, probiotics/prebiotics, synbiotics, and MTT - and their effectiveness in changing the gut microbiota and improving gastrointestinal and neurobehavioral symptoms in ASD.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/40376856/",
    "clean_text": "interventions targeting the gut microbiota and their possible effect on gastrointestinal and neurobehavioral symptoms in autism spectrum disorder the modulation of the gut microbiota using mtt in asd has shown beneficial and long term effects on gi symptoms and core symptoms of autism this review examines the current clinical research evidence for the use of interventions that target the microbiome autism spectrum disorder asd is a developmental disorder that is characterized by deficits in social communication and restricted repetitive and stereotyped behaviors in addition to neurobehavioral symptoms children with asd often have gastrointestinal symptoms e g constipation diarrhea gas abdominal pain reflux several studies have proposed the role of gut microbiota and metabolic disorders in gastrointestinal symptoms and neurodevelopmental dysfunction in asd patients these results offer promising avenues for novel treatments of this disorder interventions targeting the gut microbiota such as fecal microbiota transplant fmt microbiota transplant therapy mtt probiotics prebiotics synbiotics antibiotics antifungals and diet promise to improve gut health and can potentially improve neurological symptoms the modulation of the gut microbiota using mtt in asd has shown beneficial and long term effects on gi symptoms and core symptoms of autism also the modulation of the gut microbiota to resemble that of typically developing individuals seems to be the most promising intervention as most of the studies carried out with mtt are open label studies more extensive double blinded randomized control trials are needed to confirm the efficacy of mtt as a therapeutic option for asd this review examines the current clinical research evidence for the use of interventions that target the microbiome such as antibiotics antifungals probiotics prebiotics synbiotics and mtt and their effectiveness in changing the gut microbiota and improving gastrointestinal and neurobehavioral symptoms in asd"
}